| Rational design and implementation of a chemically inducible heterotrimerization system HD Wu, M Kikuchi, O Dagliyan, AK Aragaki, H Nakamura, NV Dokholyan, ... Nature methods 17 (9), 928-936, 2020 | 40 | 2020 |
| A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancer MT Khan, JJ Irlam-Jones, RR Pereira, B Lane, HR Valentine, K Aragaki, ... British journal of cancer 125 (1), 85-93, 2021 | 9 | 2021 |
| Gender-specific stratification of survival following immune checkpoint inhibitor therapy based on intratumoral expression of a B cell gene signature AK Aragaki, J Hoffman-Censits, NM Hahn, DJ McConkey, BA Johnson Cancer Research 81 (13 Supplement), 970-970, 2021 | 9 | 2021 |
| Abstract B010: Tumor B8T expression stratifies overall survival in high risk muscle invasive urothelial carcinoma R Elias, AK Aragaki, JH Hoffman-Censits, NM Hahn, DJ McConkey, ... Clinical Cancer Research 30 (10_Supplement), B010-B010, 2024 | | 2024 |
| Control of the Basal Molecular Subtype of Murine Bladder Cancer by Adaptive Immunity BA Johnson, M Feng, W Choi, G Colocho, A Arbuiso, S Jin, AK Aragaki, ... Cancer Research 83 (7_Supplement), 612-612, 2023 | | 2023 |
| The indoleamine 2, 3 dioxygenase pathway drives intratumoral B cell maintenance BA Johnson III, AK Aragaki, DM Williams, O Rogers, J Mountain, L Luo, ... bioRxiv, 2021.08. 25.456776, 2021 | | 2021 |
| Kisspeptin Amplifies GLP‐1 Potentiation of Insulin Secretion by a cAMP Independent Pathway RM Lynch, KA Aragaki, E Harnois, J Vagner, C Weber The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
| Enhancing β‐cell Sensitivity to Kisspeptin via Linkage to GLP‐1 AK Aragaki, C Weber, J Vagner, R Lynch The FASEB Journal 32, 807.11-807.11, 2018 | | 2018 |
